Research Article

Multifunctional Phytocompounds in Cotoneaster Fruits: Phytochemical Profiling, Cellular Safety, Anti-Inflammatory and Antioxidant Effects in Chemical and Human Plasma Models In Vitro

Table 3

UHPLC-PDA-ESI-MS3 data of polyphenols identified in the polar extracts from Cotoneaster fruits.

NumberCompoundsUV(M-H)m/zMS/MS m/z (% base peak)CLCDVCHRCNCHCDLCSCBCZ
%b

1Vanillic acid-hexoside3.5250, 290329MS2: 167 (100); 123 (2); 107 (4)3.83.13.43.42.51.42.30.91.7
2Unidentified4.4250, 295255MS2: 165 (23)33.93.12.116.15.75.02.63.13.2
33-O-Caffeoylquinic acid6.0294, 325353MS2: 191 (100); 179 (47); 135 (6)1.810.45.315.15.15.18.15.71.9
43-O-p-Coumaroylquinic acid9.4285, 310337MS2: 163 (100); 119 (10)2.15.04.02.31.92.43.73.32.5
5Caffeic acid hexoside9.8290, 323341MS2: 179 (100); 135 (10)2.38.22.75.11.20.62.51.02.8
6Unidentified10.0285, 323439MS2: 391 (100); 338 (17); 243 (10); 195 (55)3.91.94.34.82.31.22.01.31.3
75-O-Caffeoylquinic acid (chlorogenic acid)a10.4294, 325353MS2: 191 (100); 179 (6)29.428.329.526.023.523.017.917.310.8
84-O-Caffeoylquinic acid10.9294, 325353MS2: 191 (21); 179 (47); 173 (100)1.14.12.45.11.01.42.42.12.0
9Procyanidin B-type dimer13.7280577MS2: 451 (30); 425 (100); 407 (55); 289 (10)
MS3 (425): 407 (80); 273 (13)
0.71.60.51.21.11.20.9nd0.7
10Procyanidin B-2a14.9280577MS2: 451 (25); 425 (100); 407 (62); 289 (14);
MS3 (425): 407 (95); 273 (9)
0.32.54.60.88.06.25.59.310.2
115-O-p-Coumaroylquinic acid15.7285, 310337MS2: 191 (100); 163 (7)11.73.11.23.61.20.60.81.41.9
12(−)-Epicatechina16.4280289MS2: 245 (100); 205 (28)2.44.48.52.115.812.39.718.634.4
13Procyanidin B-type dimer17.3280577MS2: 451 (25); 425 (100); 407 (45); 289 (6);
MS3 (425): 407 (75); 273 (9)
ndndndnd0.4nd0.60.91.2
14Procyanidin B-type tetramer18.32801153MS2: 1027 (15); 863 (80); 739 (15); 501 (05); 491 (58); 289 (100)ndndndnd1.0nd0.61.11.4
15Procyanidin C-1a20.6280865MS2: 847 (19); 739 (77); 713 (51); 695 (100); 577 (26);
MS3 (713): 695 (100); 561 (30); 543 (31); 425 (32); 407 (36)
0.51.93.2nd5.33.73.35.67.3
16Procyanidin B-type tetramer23.32801153MS2: 863 (90); 739 (10); 501 (65); 491 (62); 289 (100)ndnd2.1nd2.72.22.02.73.5
17Quercetin 3-O-β-D-(2-O-β-D-xylosyl)galactosidea23.9268, 355595MS2: 463 (10); 445 (14); 300 (85);
MS3 (463): 343 (62); 301 (100)
ndnd4.0nd2.02.616.15.9nd
18Epicatechin derivative26.2280739MS2: 587 (100); 451 (19); 339 (40); 289 (35)nd2.22.0nd1.1nd1.51.2nd
19Unidentified26.3280451MS2: 341 (100); 217 (8)nd2.52.62.41.52.02.01.21.2
20Quercetin rhamnoside-hexoside26.7275, 350609MS2: 301 (100)0.60.41.4nd0.73.22.30.91.8
21Quercetin 3-O-β-D-galactoside (hyperoside)a27.1265, 355463MS2: 301 (100)2.55.04.95.55.59.55.26.62.4
22Querectin 3-O-β-D-(6-O-α-L-Rhamnosyl)glucoside (rutin)a27.3260, 355609MS2: 301 (100)0.82.52.62.83.82.52.0nd2.2
23Quercetin 3-O-β-D-glucoside (isoquercitrin)a28.0265, 355463MS2: 301 (100)1.63.12.42.43.52.53.32.63.2
24Procyanidin B-type dimer28.6280577MS2: 425 (100); 407 (52); 289 (18)0.61.62.01.01.62.01.62.02.4
25Quercetin rhamnoside-hexoside31.3276, 350609MS2: 301 (100)nd2.22.2nd0.44.1nd2.9nd
26Quercetin 3-O-α-L-rhamnoside (quercitrin)a32.4276, 350447MS2: 301 (100)nd2.82.2nd1.45.11.82.6nd

aIdentified with the corresponding standards; brelative contribution based on peak area on the UHPLC chromatograms ( = 280 nm) recorded at the extract concentration of 10 mg/mL and injection volume of 3 μL; nd—not detected; the values are means (); with RSD ≤ 5%. CL, C. lucidus; CDV, C. divaricatus; CHR, C. horizontalis; CN, C. nanshan; CH, C. hjelmqvistii; CDL, C. dielsianus; CS, C. splendens; CB, C. bullatus; CZ, C. zabelii.